Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Viking Global Investors LP increased its holdings in Anthem by 190.5% during the 4th quarter. Viking Global Investors LP now owns 2,537,576 shares of the company’s stock worth $570,980,000 after purchasing an additional 1,664,112 shares in the last quarter. Allianz Asset Management GmbH increased its holdings in Anthem by 66.0% during the 4th quarter. Allianz Asset Management GmbH now owns 1,603,619 shares of the company’s stock worth $360,830,000 after purchasing an additional 637,439 shares in the last quarter. Farallon Capital Management LLC increased its holdings in Anthem by 291.9% during the 4th quarter. Farallon Capital Management LLC now owns 823,000 shares of the company’s stock worth $185,183,000 after purchasing an additional 613,000 shares in the last quarter. Vulcan Value Partners LLC increased its holdings in Anthem by 52.1% during the 4th quarter. Vulcan Value Partners LLC now owns 1,327,283 shares of the company’s stock worth $298,652,000 after purchasing an additional 454,892 shares in the last quarter. Finally, HealthCor Management L.P. bought a new position in Anthem during the 4th quarter worth about $71,144,000. Institutional investors and hedge funds own 88.53% of the company’s stock.
Cypress Capital Management LLC lowered its position in Anthem (NYSE:ANTM) by 12.5% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,059 shares of the company’s stock after selling 724 shares during the period. Cypress Capital Management LLC’s holdings in Anthem were worth $1,111,000 as of its most recent SEC filing.
In related news, insider Joseph Swedish sold 27,846 shares of the firm’s stock in a transaction dated Monday, March 5th. The shares were sold at an average price of $231.12, for a total value of $6,435,767.52. Following the completion of the sale, the insider now directly owns 84,545 shares in the company, valued at approximately $19,540,040.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO John E. Gallina sold 24,576 shares of the firm’s stock in a transaction dated Monday, March 5th. The shares were sold at an average price of $229.81, for a total transaction of $5,647,810.56. Following the completion of the sale, the chief financial officer now owns 22,139 shares of the company’s stock, valued at $5,087,763.59. The disclosure for this sale can be found here. Insiders sold a total of 134,264 shares of company stock valued at $30,563,060 over the last quarter. 0.31% of the stock is currently owned by company insiders.
ANTM has been the subject of a number of research reports. Cowen reiterated a “buy” rating and set a $280.00 target price on shares of Anthem in a report on Wednesday, January 31st. Cantor Fitzgerald reiterated a “buy” rating and set a $275.00 target price on shares of Anthem in a report on Friday, January 19th. Jefferies Group upgraded Anthem from a “hold” rating to a “buy” rating and lowered their target price for the stock from $235.00 to $211.00 in a report on Friday, January 12th. ValuEngine upgraded Anthem from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Finally, Zacks Investment Research upgraded shares of Anthem from a “hold” rating to a “buy” rating and set a $252.00 price objective for the company in a research note on Monday, April 9th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. Anthem presently has a consensus rating of “Buy” and a consensus target price of $249.00.
Anthem stock opened at $224.10 on Wednesday. Anthem has a one year low of $174.96 and a one year high of $267.95. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.49 and a quick ratio of 1.49. The stock has a market cap of $58.51 billion, a PE ratio of 18.02, a price-to-earnings-growth ratio of 1.28 and a beta of 0.87.
Anthem (NYSE:ANTM) last issued its earnings results on Wednesday, April 25th. The company reported $5.41 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $4.83 by $0.58. Anthem had a net margin of 4.60% and a return on equity of 12.77%. The business had revenue of $22.34 billion during the quarter, compared to the consensus estimate of $22.55 billion. During the same period last year, the business posted $4.68 EPS. Anthem’s revenue was up .1% on a year-over-year basis. sell-side analysts expect that Anthem will post 15.38 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, June 25th. Investors of record on Friday, June 8th will be paid a $0.75 dividend. The ex-dividend date is Thursday, June 7th. This represents a $3.00 annualized dividend and a yield of 1.34%. Anthem’s dividend payout ratio (DPR) is currently 24.92%.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.